-

Augmedics adds Medtronic AI expert as VP R&D

CHICAGO--(BUSINESS WIRE)--Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced the appointment of Tal Davidson, MD as Vice President, Research & Development. Davidson was most recently AI Research Director and Site Lead for Medtronic’s Visionsense, the R&D site leading the development of intraoperative visualization and AI opportunities in minimal invasive surgery central to Medtronic’s OR of the Future strategic initiative.

The news comes a month after Augmedics strengthened its AR and AI portfolio with the acquisition of intellectual property and digital health assets from Surgalign and Holo Surgical following a competitive auction process supervised by the US Bankruptcy Court.

“The future of spine navigation exists at the intersection of best-in-class advanced visualization and decision support,” said Augmedics President & CEO Kevin Hykes. “Tal’s multidisciplinary leadership in intraoperative imaging & artificial intelligence is a tremendous asset as we build out the next generation of the xvision platform and continue our mission to deliver improved surgical outcomes for surgeons and their patients. We are proud to welcome Tal to the Augmedics team.”

Augmedics closed an $82.5 million financing round earlier this summer. The company celebrated its 25,000th screw implanted using the xvision system in September.

About Augmedics

Augmedics pioneers cutting-edge augmented reality technologies to improve surgical outcomes. The company’s revolutionary xvision Spine System® allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The first-of-its-kind, FDA-cleared xvision has been used to treat over 4,500 patients and implant more than 25,000 pedicle screws across 21 US states. xvision has consistently demonstrated 97-100% accuracy of pedicle screw placement across multiple patient studies.

Augmedics has received numerous honors, including being named a 2021 Index Awards Finalist, a Fast Company World Changing Ideas Awards 2021 Finalist, and one of Time Magazine’s Best Inventions of 2020. It was recently featured in The Economist documentary How will businesses use the metaverse?

To learn more or schedule an xvision demo, visit augmedics.com.

Contacts

Alexa Bourdage
info@augmedics.com

More News From Augmedics

Augmedics Completes 10,000th Augmented Reality Spine Surgery With xvision Spine System

CHICAGO--(BUSINESS WIRE)--Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced it has treated 10,000 patients with the xvision Spine System®. The landmark achievement marks a new record for the use of augmented reality navigation for spine surgery. “Since inception, Augmedics has been a company of firsts – the first FDA-cleared AR navigation system for surgery, the first augmented reality spine surgeries in US, the first AR clinical accuracy studies,” said Augmedi...

Augmedics Appoints Paul Ziegler as President and Chief Executive Officer

CHICAGO--(BUSINESS WIRE)--Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced Paul Ziegler as President and Chief Executive Officer. With the appointment, Gwen Watanabe will transition from interim CEO and serve as Vice Chair of the Board. Ziegler, a 20-year medical device veteran, joins Augmedics with a proven track record in commercial and operational disciplines while scaling high-growth companies. He assumes leadership as the company enters a new phase of com...

Augmedics Announces FDA Clearance, Completion of First Surgery for New CT-Fluoro Registration

CHICAGO--(BUSINESS WIRE)--Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced FDA 510(k) clearance of a new registration method for its xvision Spine System®. The xvision CT-to-fluoroscopy (CT-Fluoro) registration method allows surgeons to navigate off a preoperative CT scan and fluoroscopic images from a standard 2D C-arm, eliminating the need for 3D intraoperative imaging, a common barrier to navigation adoption. Augmedics also shared the successful completion...
Back to Newsroom